Heart drug hope: can sotagliflozin help HCM patients breathe easier?
Symptom relief
Recruiting now
This study tests an investigational drug called sotagliflozin in 500 adults with hypertrophic cardiomyopathy (HCM) who still have symptoms like shortness of breath or chest pain. Participants will receive either the drug or a placebo for 26 weeks. The main goal is to see if the d…
Phase: PHASE3 • Sponsor: Lexicon Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 10:27 UTC